Targeting synaptic pathology with a novel affinity mass spectrometry approach

Ann Brinkmalm1, Gunnar Brinkmalm2, William G Honer3

  • 1From the ‡Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, S43180 Mölndal, Sweden; ann.brinkmalm@neuro.gu.se.

Summary

Researchers developed a new method to measure synaptic proteins in brain tissue. This technique revealed changes in presynaptic proteins in Alzheimer's disease and prion infections.